-
Newest One is a dual-action injectable combining polynucleotides and hyaluronic acid. Backed by HPT™ technology, it targets hydration, tissue repair, and visible skin revitalisation—ideal for advanced skin rejuvenation protocols.
Lumifil, a global company based in the UK, manufactures a range of Premium HA Dermal Fillers that have been successfully clinically trialed against some of the worlds leading brands. Outstanding results have been achieved.
IMPORTANT INFORMATION
USEFUL LINKS
Disclaimer: Information on this site and any products mentioned on this site are not intended to be taken as medical advice or acted upon, nor diagnose, treat, cure, alleviate or prevent any diseases. None of the statements made on this website are intended to be taken as professional medical advice. We recommend that you should seek medical advice from a qualified health care professional before you act on any of the information found on this website. Any and all trademarks, logos brand names and service marks displayed on this website are the registered or unregistered trademarks of their respective owners.
Lumifil, a global company based in the UK, manufactures a range of Premium HA Dermal Fillers that have been successfully clinically trialed against some of the worlds leading brands. Outstanding results have been achieved.